Lower Drug Costs, Higher Utilization Observed in Diabetes Patients Enrolled in Medicaid
Out-of-pocket costs for noninsulin medications were 84.4% to 95.2% lower in Medicaid than in Marketplace plans, while out-of-pocket costs for insulin were 76.7% to 94.7% lower.
Significant Increase in Diabetes Prevalence Observed in China
The estimated prevalence of diabetes increased from 10.9% in 2013 to 12.4% in 2018, without a significant improvement seen in adequate treatment.
Low Use of GLP-1 RAs Observed in Treatment of Type 2 Diabetes
Data show Asian, Black, and Hispanic patients and those with lower income were less likely to receive treatment with GLP-1 RAs.
James Shapiro, MD: Insulin Production In T1D Patients After Stem Cell Therapy
Dr. Shapiro discusses the implantable VC-02 device success in producing C-peptide in patients with type 1 diabetes and what is coming next.
Teplizumab Shows the Future Promise, Current Limitations of Diabetes Care
A high-potential drug for type 1 diabetes may not have received regulation this year, but it sparked vital conversation among experts.
Fish Oil, DASH Diet Partially Alters Lipid Metabolism in Patients with Type 2 Diabetes
Fish oil intervention and DASH diet show no statistically significant effect on
glycemic control and adiposity.
Bisphenol-A Linked to Insulin Resistance in Diabetic Patients
Participants with diabetes mellitus specifically were more prone to develop insulin resistance due to BPA exposure as compared to non-diabetic participants
New Study Details PWT2D Experiences with Basal Insulin Titration
Of the 416 basal insulin initiators, only one-third of them reached the appropriate fasting blood glucose level.
Phil Zeitler, MD: Risk Factor Development in Youth-Onset Type 2 Diabetes
Dr. Zeitler highlights the long-term microvascular risk complications observed in T2D patients in the TODAY2 observational study.
Greater Reductions in HbA1c in Insulin-Naïve PW2D Treated with Gla-300
These reductions, investigators noted, were slightly greatest yet not statistically significant.
Diabetes Cardiorenal & Metabolism Institute Share New Care Recommendations
The DCRM Task Force recommendations were described as first-of-its-kind guidance for patients with overlapping diabetic, cardiorenal and metabolic disease.
Triple Therapy In T2D Care Linked To Lower Rate Of Hepatic Steatosis, Fibrosis
Patients with type 2 diabetes treated with triple therapy had less hepatic steatosis and fibrosis and significantly improved insulin sensitivity versus conventional therapy.
Investigators Confirm Efficacy of Dasiglucagon for Treatment of Hypoglycemia
The team estimated the time to individual plasma glucose recovery following exposure to the medication.
Hyperinsulinemia Rates in US Adults Significantly Increased Over 20 Year Period
Data show the age-adjusted prevalence of hyperinsulinemia in adults without diabetes increased by 18% in the study population between 1999 - 2000 and 2017 - 2018.
Severe COVID-19 Symptoms Recorded in Patients with Nonalcoholic Fatty Liver Disease
In keeping with earlier data, investigators suggested that metabolic syndrome was associated with severe cases of infection.
Clinical, Genetic Characteristics in Neonatal Diabetes Cohort Similar to Previous Data
A NDM cohort in Israel found those with TNDM were taller and heavier compared to PNDM, while chronic diabetes complications developed in patients with long-standing NDM.
FDA Grants Breakthrough Device Designation to Insulin Patch Pump
The ergonomic device for the treatment of diabetes is the only insulin patch pump for closed loop integration able to be used with standard, pre-filled pump cartridges.
Stem Cell Therapy Restores Insulin Production in Patients with Type 1 Diabetes
VX-880 stem cell-derived therapy demonstrated restoration of insulin production and was generally well-tolerated in T1D treatment.
3 Things Primary Care Providers Need to Know About Continuous Glucose Monitoring Technology
CaFFR Guided Revascularization Show Reduced MACE Risk in Diabetic Patients with CAD
Patients considered adherent to caFFR had a significantly lower risk of MACE, compared to non-adherent patients (adjusted hazard ratio, 0.33).
Negative Affect, Disinhibited Eating Found In Youth Genetically Predisposed to T2D
In models adjusting for age, sex, and race/ethnicity, children with a parent with type 2 diabetes reported higher symptoms of anxiety and depression.
SGLT2 Inhibitors Associated With High Hemoglobin Level, Low Prevalence of Anemia
Data show hemoglobin level of SGLT2 inhibitor users were higher at an eGFR above >15 mL/min/1.73m2 compared to non-users.
Obesity Prevalence in United States Linked To Significant Increase Over 4 Decades
From 1976 to 2018, data show the prevalence of obesity in the United States increased from 6.2% to 32.7%.
Younger Adults With Diabetes Report Low Receipt of Healthcare During COVID-19
Adults aged 18–29 years (87%) with diabetes were more likely to report missed medical care during COVID-19, compared to those aged 30–59 years (63%) or ≥60 years (26%).
Real-World Evidence Shows Automated Insulin Dosing Safe, Effective Treatment for T1D
Investigators noted that several types of AID systems improved Time-in-Range and HbA1c with minimal concerns around severe hypoglycemia in type 1 diabetes care.
Doctors Weigh Cardiovascular Risk Reduction Over Side Effects for Antihyperglycemic Agents
The least selected attributes were food and medication restrictions and A1c lowering followed by risk of diabetic ketoacidosis, risk of genital infection, and the avoidance of severe hypoglycemia.
Decrease in Average Weekly Insulin Prescription Fills Observed During COVID-19
A significant decrease of -55.3 insulin fills per week during the pandemic was observed, in comparison to before the pandemic.
Sulfonylurea Deintensification Rates Low After Hospitalization for Hypoglycemia
Sulfonylurea and/or insulin deintensification occurred in fewer than 50% of older adults with diabetes within 100 days of a hypoglycemia-associated ED visit.
Examining the Prevalence of Celiac Disease in Patients with Type 1 Diabetes Mellitus
This study found that compared with the general population, the prevalence of celiac disease in people with type 1 diabetes mellitus is increased.
Visceral Fat Associated With Increased Arterial Stiffness in Youth With Obesity
Data show In youth with obesity, but not healthy weight, visceral fat was positively associated with PWV and was predictive of PWV beyond BMI and waist circumference.
2 Clarke Drive Cranbury, NJ 08512